Supplemental material
Human Vaccines & Immunotherapeutics
Volume 20, 2024 - Issue 1
Licensed Vaccines
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule
Federico Martinón-Torresa Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain;b Genetics, Vaccines and Infectious Diseases Research Group (GENvip), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain;c Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain
https://orcid.org/0000-0002-9023-581XView further author information
https://orcid.org/0000-0002-9023-581XView further author information, Ignacio Salamanca de la Cuevad Instituto Hispalense de Pediatría, Sevilla, Spainhttps://orcid.org/0000-0003-0561-9913View further author information
https://orcid.org/0000-0003-0561-9913View further author information, Michael Horne Praxis Dr. med. Michael Horn, Bayern, Schoenau am Koenigssee, Germanyhttps://orcid.org/0000-0002-4699-5969View further author information
https://orcid.org/0000-0002-4699-5969View further author information, , Samantha Bosisg Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italyhttps://orcid.org/0000-0003-2288-2633View further author information
https://orcid.org/0000-0003-2288-2633View further author information, Nadia Meyerh GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-7423-0226View further author information
https://orcid.org/0000-0002-7423-0226View further author information, Brigitte Cheuvarth GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-7156-0062View further author information
https://orcid.org/0000-0001-7156-0062View further author information, Navpreet Virki GSK, Mumbai, Indiahttps://orcid.org/0000-0003-4355-0101View further author information
https://orcid.org/0000-0003-4355-0101View further author information, Rupert W. Jakesj GSK, London, UKhttps://orcid.org/0000-0002-3837-8063View further author information
https://orcid.org/0000-0002-3837-8063View further author information, Maurine Duchenneh GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-5292-3630View further author information
https://orcid.org/0000-0001-5292-3630View further author information & Peter Van den Steenh GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0001-7931-1781View further author information
https://orcid.org/0000-0001-7931-1781View further author information show all